Clinical Trials
4 trialsNCT00433511 2026-05-29
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT06977412 2025-05-18
The Application Value of Spectral CT in the Accurate Staging of Breast Cancer
Yunnan Cancer Hospital
Phase NA Not yet recruiting
NCT06671262 2025-02-11
NEOTRIO-HR
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT02282345 2022-07-06
Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Completed